2026 Volume 29 Number 3
The electronic edition – Free
Print version
In this issue:
Original Research
Changes in the Bacterial Microflora of Urine in Patients with Type 2 Diabetes Mellitus and Urolithiasis
Hepatotoxicity of Anti-Inflammatory Drugs Used to Treat Gout Attacks
Clinical and Pathophysiological Analysis of Colon Cancer (C18) Incidence in the Gomel Region: the Role of Endogenous and Exogenous Factors in Pathogenesis
Reviews and Lectures
Monitoring Alcohol Withdrawal Syndrome in the Intensive Care Unit (ICU): a Critical Review of Classical Scales
Interstitial Lung Diseases: Pathogenetic Aspects, Modern Approaches in the Diagnosis of Interstitial Lung Diseases with Progressive Fibrosis
Pharmacoeconomics
Pharmacoeconomic Evaluation of the Fixed Combination of Vildagliptin/Metformin (Agarta® Met) in the Treatment of Patients Aged 18 and Older with Type 2 Diabetes Mellitus
Therapy
The Silent Guardians of Stomach Acidity: the Evolution of Proton Pump Inhibitors Over the Past 5 Years
Modern Strategies for the Treatment of Bronchial Asthma
Ademetionine as a Universal Hepatoprotector: Proven and Possible
Clinical Сase
Secondary Pneumomediastinum: Case Series
Editorial
Л.Н. Гавриленко, главный редактор
Уважаемые коллеги, читатели журнала «Рецепт»!
С 18 по 23 мая 2026 года состоялся IV Российский конгресс «Безопасность фармакотерапии 360°: Noli nocere!» с международным участием. Конгресс прошел в смешанном формате и объединил ведущих экспертов в области клинической фармакологии, фармаконадзора, персонализированной медицины и организации здравоохранения.